Splash Beverage posts 64% Q2 loss improvement
Splash Beverage reported a strengthened balance sheet and expanded its pharmaceutical cannabinoids pipeline via licensing deals, signaling a shift towards Endovia Health Sciences.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day